INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.30
-1.00 (-15.87%)
At close: Oct 23, 2025
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 418.19 million as of October 24, 2025. Its market cap has increased by 25.77% in one year.
Market Cap
418.19M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.30
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 418.19M, a decrease of -7.56%. That is a compound annual growth rate of -2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 418.19M | 10.87% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.40B |
| Nordhealth AS | 2.83B |
| ArcticZymes Technologies ASA | 1.53B |
| Photocure ASA | 1.40B |
| Thor Medical ASA | 1.23B |
| Omda AS | 972.06M |
| Vistin Pharma ASA | 962.28M |
| Gentian Diagnostics ASA | 848.23M |